Skip to main content
VCbacked
Log inGet Started

VIAN Therapeutics

San Francisco, United States

VIAN Therapeutics is an ophthalmology pharma startup combating microvascular retinal diseases (AMD and DME) with a simple eyedrop.

$1.0M raised
Jun 2024
Seed
BiotechnologyMedicalPharmaceutical

Top Investors

Ulu VenturesSOSVSOSV SF & NY (Fka IndieBio)Sand Hill AngelsSeedFolio

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about VIAN Therapeutics

How much funding has VIAN Therapeutics raised?
VIAN Therapeutics has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in June 2024.
Who are VIAN Therapeutics's investors?
VIAN Therapeutics's investors include Ulu Ventures, SOSV, SOSV SF & NY (Fka IndieBio), Sand Hill Angels, SeedFolio.
Where is VIAN Therapeutics headquartered?
VIAN Therapeutics is headquartered in San Francisco, United States.
What does VIAN Therapeutics do?
VIAN Therapeutics is an ophthalmology pharma startup combating microvascular retinal diseases (AMD and DME) with a simple eyedrop.
What stage is VIAN Therapeutics at?
VIAN Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"VIAN Therapeutics — Funding & Investors." VCBacked, June 25, 2024, https://www.vcbacked.co/company/vian-therapeutics. Accessed July 4, 2026.
APA
VCBacked. (2024). VIAN Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/vian-therapeutics
Wikipedia (cite web)
{{cite web |title=VIAN Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vian-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K